ArticleScientific reports2019

Nicotinamide phosphoribosyltransferase is a molecular target of potent anticancer agents identified from phenotype-based drug screening.

Daisuke Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.